Skip to main content
Archean Sciences logo

Archean Sciences

Champaign, Illinois, United StatesSee on the mapFounded 2026

  • Brain-computer interfaces
  • Neuroscience research tools
  • Seed

Archean Sciences engineers living neural tissue for applications in human health and biohybrid computing. Its platform combines neural tissue with custom hardware and software to automate experiments, maintain culture health, and program neural activity.

Raised
$770K
Aug 2026
Seed
Investors
3
Founded
2026
Employees
2–10

reccy insights

Recent highlights

Archean Sciences was founded in 2026 and is developing an autonomous brain-on-a-chip platform that combines living human neurons with custom hardware and software. A grant is listed on Apr 17, 2026, with TechNexus Venture Collaborative, Origin Ventures Group, and Illinois Ventures named as leads; no grant amount is specified. The company’s Seed financing is dated Aug 13, 2026, with structured funding data listing $385,000 and a broad group of named investors, including TechNexus Venture Collaborative, Origin Ventures Group, Sweet Spot Capital, Multimodal Ventures, and Illinois Ventures. A separate $385,000 SAFE offering is also dated that day. Hiring signals describe 150% quarter-over-quarter growth, from two to five employees, while the structured employee count is two. No product launch, partnership, award, or leadership-change announcements are included in the available company profile. The clearest milestones are therefore its 2026 financing activity and early team growth, rather than publicly described commercial deployments or clinical results.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes Archean Sciences distinct

  1. 01Integrates living neural tissue with custom hardware and software in one platform.
  2. 02Automates neuroscience experiments and supports neural culture health and activity programming.
  3. 03Targets both neurological drug discovery and biohybrid computing applications.
  4. 04Combines neuroengineering, scientific operations, and neuroscience expertise.

Technology & products

  • Autonomous brain-on-a-chip platform

    An AI-powered biological platform that interfaces living human neurons with custom hardware and software to automate in vitro neuroscience experiments, maintain neural culture health, and program neural activity.

  • Neural tissue platform integrated with custom hardware and software.
  • Automated experimentation and neural culture health maintenance.
  • Neural activity programming.

Funding

$770K disclosed
3 investors

Investors13

Also backed by
  • TechNexus Venture Collaborative
  • Origin Ventures Group
  • Illinois Ventures
  • Sweet Spot Capital
  • Multimodal Ventures
  • Automated Deal Investing Network
  • Origin Ventures II Management, LLC

Similar companies

About Archean Sciences

Products
Autonomous brain-on-a-chip platform
Leadership
Austin Ellis-MohrMattia Gazzola
Focus areas
NeuroTechnology, biotech, research tools, hardware, medical devices, biohybrid computing, neural tissue, neuroscience
Headquarters
Champaign, Illinois, United States
Founded
2026
Employees
2–10
Status
Active · private